HANCOCK THOMAS 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Jul 12, 2018
Insider Transaction Report
Form 4
HANCOCK THOMAS
Director
Transactions
- Award
Stock Option (right to buy)
[F1]2018-07-10+50,000→ 50,000 totalExercise: $0.57Exp: 2028-07-10→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to 100% of the shares underlying the Option on July 10, 2019.
Signature
/s/ Robert A. Petitt, Attorney-in-Fact (Signed under power of attorney on behalf of Reporting Person)|2018-07-12